This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The surge in MASH cases stresses the need for early diagnosis, timely intervention and precise, reliable methodologies in clinicaltrials to evaluate new therapies effectively. Read on to gain insights from Medpace experts about advancements in imaging, histology and innovative techniques for MASH clinicaltrials.
By Luisa Sterkel & Joana Loureiro , Tenthpin Consultants The promise and potential of cell and gene therapies (CGT) has emerged in the recent past and currently over 1.500 CGT are registered for clinicaltrials holding great hope for the treatment of challenging and uncurable diseases.
This week, were celebrating a significant milestone: the release of our 200th episode of the Xtalks LifeScience Podcast ! We’re excited to continue our journey by bringing you more in-depth conversations with industry leaders, highlighting the innovations and trends that shape the future of lifesciences.
Clinicaltrials have been steadily leaving the UK for years. of patients recruited to global trials were from the UK. Thats not to say we dont still have some clout (the UK ranks fourth globally for Phase II trials ), but the trending outflow needs to be addressed. In 2021, just 2.2%
Allergan Aesthetics is focused on creating products and technologies that drive the advancement of aesthetic medicine. Dr. Manson Brown’s Clinical Development and Scientific Innovation team are responsible for global clinicaltrial development strategy for the Aesthetic Medicine portfolio, covering pharmaceuticals and device.
This year, Camargo is highlighting one of our own, Manager of LifeScience Solutions Andrea Miller, who cared for her husband Tom throughout his battle with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease. We were getting tools to help manage our lives and medicines to manage Tom’s symptoms.
A successful lifescience webinar engages the audience in a unique manner, drives the right kind of traffic and provides genuine value for attendees. Here are 5 trending lifescience webinar topics that have been resonating well with our audiences. Decentralized ClinicalTrials, Hybrid Trials & Virtual Trials .
In the lifesciences, countless Black scientists, researchers and medical professionals have made groundbreaking discoveries that have significantly advanced our understanding of biology and medicine. They serve as inspiration for future generations of scientists from all backgrounds.
As we step into 2024, the lifesciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables. These companies are at various stages of research and clinicaltrials.
Before beginning his career in industry in 2007, Dr. Culleton was a Clinical Associate Professor in the Department of Medicine at the University of Calgary. The candidate is currently being evaluated in Phase II and Phase III clinicaltrials. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
BlueRock Therapeutics, a subsidiary of Bayer AG, is making waves in the treatment of Parkinsons disease by advancing its investigational cell therapy, bemdaneprocel, to a Phase III clinicaltrial. In the Phase I trial, 12 participants received the therapy and were observed for two years. As of 2023, there were approximately 2.7
The company plans to use these funds to advance its groundbreaking research in small molecule precision medicines, targeting renal, cardiovascular and metabolic diseases, including obesity.
Courtney Silverthorn who is an Associate Vice President at the Foundation for the National Institutes of Health (FNIH) and the Director of the Accelerating Medicines Partnership (AMP) program including the Bespoke Gene Therapy Consortium. Xtalks spoke with Dr. Silverthorm about the consortium’s new rare disease clinicaltrial portfolio.
OncoImmune was founded in 2000 based on the scientific discoveries of the company’s founders who moved their lead product from a basic concept into clinicaltrials for multiple indications. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
Whether it’s for a treatment for a chronic ambulatory condition, precision medicine or cell and gene therapy, there is a massive uptick in clinicaltrial complexity. It’s important to make sure that with this increase in clinicaltrial complexity, we don’t make our trials overly burdensome to sites or patients,” says Markham.
BriaCell is developing cell therapies for the treatment of advanced breast cancer and has promising compounds, including Bria-IMT, that are currently being evaluated in clinicaltrials. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
The HALOS platform is built using an invention from the research team led by Professor Chris Scott, who is the scientific co-founder and chief scientific officer of Aviceda and interim dean of research, faculty of medicine, health, and lifesciences, at Queen’s.
In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination. Angela McFarlane ?,
The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinicaltrial space. Hybrid or decentralised clinicaltrials (DCTs) have gained traction as technology, infrastructure and knowledge have evolved to support their use. Source: Izmailova et al, 2017.
The Foundation for the National Institutes of Health (FNIH) announced this week that the Accelerating Medicines Partnership Bespoke Gene Therapy Consortium (AMP BGTC) has selected eight rare diseases for its clinicaltrial portfolio.
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinicaltrials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinicaltrial design that have historically led to trial failure?
The pandemic itself will also continue to spur innovations and changes such as greater shifts towards decentralized clinicaltrials and patient-centric approaches. In addition to vaccines, there are handfuls of drugs currently being evaluated in clinicaltrials for the treatment of COVID-19.
July is Disability Pride Month in the US and Bristol Myers Squibb has teamed up with the non-profit Disability Solutions to improve disability diversity in clinicaltrials. This initiative can pave the way for better accessibility and inclusion of people with disabilities in clinicaltrials.
Personalised medicines will also be developed at the centre. In an email to Pharmaceutical Technology , an NHSBT spokesperson said the centre will “support early phase clinicaltrials and preclinical work, providing a route to eventual commercial scale production”.
The FDA has approved Genentechs TNKase (tenecteplase) for the treatment of acute ischemic stroke in adults, marking a milestone as the first new stroke medicine approved in nearly three decades. TNKase works by initiating a biochemical reaction that breaks down fibrin, a protein that acts like the scaffolding holding blood clots together.
If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the lifesciences. Here is a look at some lifescience trends to expect in the coming year, including key themes and topics in the pharmaceutical, biotechnology and medical device industries to keep an eye out for in 2022.
This is relevant for clinicaltrials as more regulators require evidence of efficacy in comparison to the standard of care, which is likely to be one of the blockbuster products. We are experts in sourcing licensed and unlicensed medicines for use in trials, ranging from eye drops to the most sought-after blockbuster therapies.
The way in which clinicaltrials are conducted is entering a new dimension as clinicaltrial operations are becoming more adaptable. The COVID-19 pandemic certainly has pushed to the forefront of clinicaltrials, the digital evolution in clinical research. MRI scan, endoscopy, etc.)
The Foundation’s Accelerating Medicines Partnership (AMP) Bespoke Gene Therapy Consortium (BGTC) will study these eight conditions by focusing on gene therapies using adeno-associated vectors (AAV). These organisations include 12 lifescience companies, 11 NIH institutes and centres, and ten non-profit organisations.
JSR LifeSciences’ business unit Similis Bio is planning to collaborate with Novel351k for the development of three biosimilar programmes targeting cancer and autoimmune diseases. This will lead to pharmacokinetics/pharmacodynamic clinicaltrials. This will lead to pharmacokinetics/pharmacodynamic clinicaltrials.
The partnership between Abbott and non-profit Women as One will train female and underrepresented physicians to help improve diversity in clinicaltrials. In a study that analyzed the demographics of clinicaltrial participants of the 102 new drugs approved between 2013 to 2015 by the FDA’s CDER, only 40.4
In this episode, Ayesha spoke with Thomas Heineman, MD, PhD, Chief Medical Officer at Oncolytics Biotech , a company developing an oncolytic virus cancer therapeutic that is currently in clinicaltrials for indications including metastatic breast cancer and pancreatic cancer.
Proceeds from the IPO will propel key initiatives, including the Phase II clinicaltrial of Jotrol in Parkinson’s disease. In the Asia-Pacific market, Jupiter has negotiated partnerships with companies such as Sichuan Kelun and Tianjin Pharmaceuticals, focusing on Jotrol’s integration into traditional Chinese medicine frameworks.
Today is ClinicalTrials Day 2021 — a day for recognizing the importance of clinical research in protecting and improving global health. Amid the alarmist headlines posted by other media outlets, Xtalks has remained balanced in its reporting of COVID-19 clinicaltrial results and safety data.
Hear more about Neuromod’s Lenire device, including clinical and real-world data showing its effectiveness in improving symptoms of tinnitus. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
With a singular mission to end childhood cancer, the partnership will merge the unique strengths of both institutions combining clinical expertise, cutting-edge research and an expansive network of clinicaltrials to accelerate improved outcomes for young patients.
Dudley Tabakin, CEO of VivoSense, describes how this financing is set to accelerate the development of novel digital biomarkers and improve digital clinical outcome assessments. How can this data be incorporated into clinicaltrials?”. How can this data be incorporated into clinicaltrials?”. Tabakin agrees. “In
Orphan drug development poses many challenges that are unique to rare diseases, including recruitment in small patient populations, variable progression with heterogenous clinical manifestations and limited understanding of disease progression and natural history.
Pharma has a great opportunity ahead of it when it comes to conducting representative clinicaltrials. The processes used are now seeing huge infrastructure commitments, in order to cement their place in the development of future products and trials. Only then can medicines work equally for all patients. About the author.
Latest UK LifeSciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Despite the UK’s potential as an international lifesciences leader, it lags many competitors in a number of key metrics, including access to new medicines and global share of clinicaltrial recruitment.
Cardiac biomarkers can not only serve important roles in the diagnosis, management and prognosis of cardiac diseases, but they can also be significant tools in evaluating treatments in cardiovascular (CV) clinicaltrials. In CV clinicaltrials, cardiac biomarkers are most commonly included in efficacy and safety endpoints.
Dr. Yu has also led numerous clinicaltrials. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode. He has developed numerous immunotherapies and nanotechnologies from his National Institutes of Health (NIH) funded laboratory. Yu is leading at Kairos Pharma to address cancer drug resistance.
Multiple studies have confirmed that conducting clinicaltrials with a diverse range of ethnicities, genders, ages, and lifestyles is essential, since these factors can impact a treatment’s effectiveness among different groups. Despite this, ethnic minorities are underrepresented in clinicaltrials.
Yesterday, on International ClinicalTrials Day 2024, the global healthcare community came together to commemorate the significant advancements in clinical research and the vital role clinicaltrials play in improving patient care and outcomes.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content